Activator & Type II Diabetics

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT04569214` - The Efficacy and Safety of PAZ320 on PPG and Insulin Blood Levels in Type II Diabetic Patients	Phase 2
Completed	`NCT02127762` - The Effect of Mindfulness Based Stress Reduction in Patients With Painful Diabetic Peripheral Neuropathy	N/A
Completed	`NCT01698528` - Evaluation of a Prototype Diabetes Management System Applied to Insulin Initiation and Titration	N/A
Completed	`NCT00985114` - Safety and Efficacy Study of EndoBarrier in Subjects With Type II Diabetes and Obesity	N/A
Active, not recruiting	`NCT05120219` - A Study to Assess the Effect of Food on HR20033 and Pharmacokinetic After Multiple Dose in Healthy Volunteers	Phase 1
Completed	`NCT04893135` - Impact of the Rapid Normalization of Chronic Hyperglycemia and the Practice of Moderate Physical Activity on the "Receptor Activator of Nuclear Factor-kappa B Ligand / Osteoprotégérine (RANKL / OPG) System in Patients Living With Type II Diabetes	N/A
Not yet recruiting	`NCT05108350` - A Study to Assess the Bioequivalence of Fixed Dose Combination of HR20033 Relative to Co-administration of the Individual Components in Healthy Chinese Subjects	Phase 1
Completed	`NCT02586129` - Clinical Trial of YH14755 in Subjects With Dyslipidemia and Type II Diabetes	Phase 3
Completed	`NCT02914743` - Providing Preventive Periodontal Treatment to Hospitalized Patients With Diabetes	N/A
Completed	`NCT04540016` - Mass Balance and Biotransformation of [14C]HSK7653 in Human	Phase 1
Completed	`NCT02429258` - Effect of Dapagliflozin on 24-hour Blood Glucose in T2DM Patients Inadequately Controlled With Either Metformin Or Insulin	Phase 4
Completed	`NCT01055223` - Fracture Risk With Thiazolidinediones	N/A
Terminated	`NCT02365233` - Fatty Liver Study in Patients With Type II Diabetes	Phase 4
Completed	`NCT05878587` - Burger Allen Exercises in Knee OA With Type II Diabetes	N/A
Completed	`NCT04768673` - A Study to Investigate the PK and Safety of CKD-393	Phase 1
Not yet recruiting	`NCT05028140` - Efficacy and Safety of Piemonte Association in the Treatment of Type II Diabetes Mellitus	Phase 3
Terminated	`NCT01804777` - Epithelial Sodium Channel (ENaC) as a Novel Mechanism for Hypertension and Volume Expansion in Type 2 Diabetes	Early Phase 1
Completed	`NCT01619332` - Clinical Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEZ763	Phase 1/Phase 2
Active, not recruiting	`NCT06387433` - Effectiveness of an mHealth Mobile App	N/A
Not yet recruiting	`NCT01591525` - Diabetes Mellitus Community Based Screening in Minority Populations	N/A

NCT number	NCT01782092
Study type	Observational
Source	Life University
Contact
Status	Completed
Phase	N/A
Start date	August 2012
Completion date	August 2014

Activator and Type II Diabetics

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms